Clear Street’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Clear Street’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57	Hold	4,894	–	–	﹤0.01%	1079
2025 Q4	$53	Sell	4,894 -100	-2%	-$2	﹤0.01%	907
2025 Q3	$131	Buy	4,994 +4,794	+2,397%	+$127	﹤0.01%	805
2025 Q2	$6	Buy	+200	New	+$4	﹤0.01%	671
2025 Q1	–	Sell	-26,912	Closed	-$592	–	584
2024 Q4	$592	Buy	26,912 +24,700	+1,117%	+$590	﹤0.01%	510
2024 Q3	$33	Buy	2,212 +121	+6%	+$2	﹤0.01%	678
2024 Q2	$63	Hold	2,091	–	–	﹤0.01%	747
2024 Q1	$53	Buy	2,091 +100	+5%	+$4	﹤0.01%	746
2023 Q4	$62	Buy	1,991 +391	+24%	+$15	﹤0.01%	772
2023 Q3	$36	Buy	1,600 +200	+14%	+$8	﹤0.01%	1052
2023 Q2	$100	Hold	1,400	–	–	﹤0.01%	1213
2023 Q1	$206	Hold	1,400	–	–	﹤0.01%	1072
2022 Q4	$0	Hold	1,400	–	–	﹤0.01%	1081
2022 Q3	$0	Hold	1,400	–	–	﹤0.01%	1185
2022 Q2	$0	Buy	+1,400	New	+$105	﹤0.01%	1032

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clear Street's COEPW Position: Q1 2026 in Review

Clear Street held its Coeptis Therapeutics Warrants (COEPW) position steady in Q1 2026 at 4,894 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Clear Street first reported a position in COEPW in Q2 2022 and has held it in 15 quarters since. The position peaked at $592 in Q4 2024. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Clear Street held 4,894 shares of Coeptis Therapeutics Warrants worth $57 as of Q1 2026.
Clear Street left its Coeptis Therapeutics Warrants share count unchanged in Q1 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1079 holding.
Clear Street first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and has held it in 15 quarters since.
Clear Street's Coeptis Therapeutics Warrants position peaked at $592 in Q4 2024.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.